We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+2.12%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$971M
AUM Growth
-$19.4M
Cap. Flow
+$172M
Cap. Flow %
17.68%
Top 10 Hldgs %
24.54%
Holding
508
New
199
Increased
44
Reduced
12
Closed
182

Sector Composition

Rank Sector Weight
1 Financials 37.12%
2 Healthcare 13.18%
3 Technology 10.4%
4 Communication Services 6.84%
5 Energy 5.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THMAU
476
DELISTED
Thimble Point Acquisition Corp. Unit
THMAU
-300,000
Closed -$3M
FOREU
477
DELISTED
Foresight Acquisition Corp. Units
FOREU
-300,000
Closed -$2.97M
DDMX
478
DELISTED
DD3 Acquisition Corp. II Class A Common Stock
DDMX
-26,611
Closed -$260K
LIII.U
479
DELISTED
Leo Holdings III Corp Units, each consisting of one Class A ordinary share, and one-fifth of one red
LIII.U
-200,000
Closed -$1.96M
VOSOW
480
DELISTED
Virtuoso Acquisition Corp. Warrant
VOSOW
-77,841
Closed -$47K
XOG
481
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
-5,825
Closed -$209K
LEGO
482
DELISTED
Legato Merger Corp. Common stock
LEGO
-300,000
Closed -$2.9M
LEGOW
483
DELISTED
Legato Merger Corp. Warrant
LEGOW
-233,614
Closed -$112K
MAAC
484
DELISTED
Montes Archimedes Acquisition Corp. Class A Common Stock
MAAC
-74,844
Closed -$732K
LATNW
485
DELISTED
Union Acquisition Corp. II Warrant
LATNW
-22,326
Closed -$15K
PTK
486
DELISTED
PTK Acquisition Corp.
PTK
-100,000
Closed -$985K
CAHCW
487
DELISTED
CA Healthcare Acquisition Corp. Warrant
CAHCW
-100,000
Closed -$53K
CENHU
488
DELISTED
Centricus Acquisition Corp. Unit
CENHU
-300,000
Closed -$2.98M
ALXN
489
DELISTED
Alexion Pharmaceuticals
ALXN
-113,349
Closed -$17.3M
WORK
490
DELISTED
Slack Technologies, Inc.
WORK
-90,167
Closed -$3.66M
GNRS
491
DELISTED
Greenrose Acquisition Corp. Common Stock
GNRS
-53,026
Closed -$528K
AT
492
DELISTED
Atlantic Power Corporation
AT
-1,466,420
Closed -$4.24M
IPHI
493
DELISTED
INPHI CORPORATION
IPHI
-51,900
Closed -$9.26M
MSACU
494
DELISTED
Medicus Sciences Acquisition Corp. Unit
MSACU
-150,000
Closed -$1.48M
NMCI
495
DELISTED
Navios Maritime Containers L.P. Common Units
NMCI
-1,458,400
Closed -$13.5M
PUCKU
496
DELISTED
Goal Acquisitions Corp. Unit
PUCKU
-100,000
Closed -$1M
TWLVU
497
DELISTED
Twelve Seas Investment Company II Unit
TWLVU
-300,000
Closed -$2.96M
QDROU
498
DELISTED
Quadro Acquisition One Corp. Unit
QDROU
-300,000
Closed -$2.98M
ACAHU
499
DELISTED
Atlantic Coastal Acquisition Corp. Unit
ACAHU
-200,000
Closed -$1.97M
NRACU
500
DELISTED
Northern Revival Acquisition Corporation Unit
NRACU
-300,000
Closed -$2.97M

Similar funds

Mangrove Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Mangrove Partners held 508 positions worth $971M, down 2% from $991M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Mangrove Partners deployed $172M of net new capital in Q2 2021, opening 199 new positions and adding to 44 existing holdings. Its largest new stake was Coherent Inc: 74,493 shares worth $19.7M.

By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was GPGI Inc, an estimated $7.25M trimmed.

  • Mangrove Partners's largest Q2 2021 buy was Coherent Inc: 74,493 shares worth $19.7M.
  • Mangrove Partners added most to Pershing Square Tontine Holdings, Ltd. in Q2 2021, an estimated $32.9M increase.
  • Mangrove Partners's biggest Q2 2021 reduction was GPGI Inc, cutting an estimated $7.25M.
  • Mangrove Partners fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $17.3M.
  • Mangrove Partners's ten largest holdings make up 25% of its $971M portfolio in Q2 2021.
  • Mangrove Partners opened 199 new positions and closed 182 in Q2 2021.
  • Mangrove Partners's portfolio value fell 2% quarter-over-quarter to $971M.

Based on Mangrove Partners's 13F filing for Q2 2021, filed 16 Aug 2021.